DXRDaxor Corporation

$57M

Q4 2012 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1M+87.3% YoY

Gross Profit

$1M100.0% margin

Operating Income

$1M87.7% margin

Net Income

$3M250.3% margin

EPS (Diluted)

$0.72

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$10M

Stock-Based Comp.

$5,838

Balance Sheet

Total Assets

$56M

Total Liabilities

$21M

Stockholders' Equity

$35M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$638,711	+87.3%
Gross Profit	$1M	$312,456	+282.9%
Operating Income	$1M	-$3M	+136.3%
Net Income	$3M	-$4M	+183.4%

DXR Q4 2012 Earnings — Daxor Corporation Revenue & Financial Results | Market Cap Arena